News

Talcum Powder Ovarian Cancer Lawsuits

talcum-powder-lawsuit-settlement
Written by admin

According to a report the multidistrict litigation set up in prior this month for all federally-filed ovarian cancer proceedings comprising talcum powder products marketed by Johnson & Johnson will formally get underway in November. On 20th of October the District Court of New Jersey issued an Order stating that the Court will convene an Organizational Conference on Thursday, November 17th and the timing will be 10:00 a.m. The meeting will be conduct to address “housekeeping” issues in individual cases. Approximately 1,800 talcum powder lawsuits have been filed against Johnson & Johnson in courts from all over the nation. The lawsuits claim that manufacturers of talcum powder provided insufficient warnings about the severe risk associated with the talc and they withheld information about the link between talc and ovarian cancer

The U.S. Judicial Panel on Multidistrict Litigation announced an order on 4th of October stating that New Jersey will be the venue to consolidate the lawsuits linking cancer from Talcum powder usage. According to the panel, New Jersey is a convenient forum for this nationwide litigation, and is located in close proximity to a large number of state court actions pending in New Jersey. New Jersey is also the place where Johnson & Johnson headquarter located, so relevant evidence and witnesses likely are based in the District of New Jersey. Just after the order announced 11 pending cases and 43 more potential actions from around the country reassigned to U.S. District Judge Freda Wolfson of the District of New Jersey. Any future ovarian cancer claims filed in federal courts against Johnson & Johnson are likely to be transferred to New Jersey.

Recently a multi-plaintiff lawsuit has been filed in California state court alleging that the manufacturers were aware of almost 40 years of independent scientific studies which linked the use of their products to higher risk of ovarian cancer when the talc was applied in the genital area but the manufacturers decided to withheld the information as per them the risk was not significant enough to require a product warning. In this multi- plaintiff lawsuit women from all over the nation made similar claims and accuses the manufacturer of recklessly selling it products to market without warning, Due to the negligence and not adequately warning the potential ovarian cancer risks by the manufacturers thousands of women throughout the United States may have developed ovarian cancer and fighting with their lives.

Johnson & Johnson is preparing to fight another legal battle as the number of lawsuits is increasing day by day. Thousands of women have filed lawsuits across the country against Johnson & Johnson alleging that the use of talcum powder leads to ovarian cancer.  Several investigations on talc increase the medical evidence which suggest Women should not use talcum powder as an intimate hygiene powder because of its link to ovarian cancer. The more often a woman uses it on her genital area, the more likely she will experience ovarian cancer. If you’ve developed ovarian cancer and used talcum-based Johnson & Johnson powder product, such as Shower to Shower or Johnson’s Baby Powder please contact Drugsclaim.com for a free talcum powder lawsuit case review. Our accomplished lawyers are dedicated to protecting consumers through class action and individual litigation, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.

According to a report the multidistrict litigation set up in prior this month for all federally-filed ovarian cancer proceedings comprising talcum powder products marketed by Johnson & Johnson will formally get underway in November. On 20th of October the District Court of New Jersey issued an Order stating that the Court will convene an Organizational Conference on Thursday, November 17th and the timing will be 10:00 a.m. The meeting will be conduct to address “housekeeping” issues in individual cases. Approximately 1,800 talcum powder lawsuits have been filed against Johnson & Johnson in courts from all over the nation. The lawsuits claim that manufacturers of talcum powder provided insufficient warnings about the severe risk associated with the talc and they withheld information about the link between talc and ovarian cancer

The U.S. Judicial Panel on Multidistrict Litigation announced an order on 4th of October stating that New Jersey will be the venue to consolidate the lawsuits linking cancer from Talcum powder usage. According to the panel, New Jersey is a convenient forum for this nationwide litigation, and is located in close proximity to a large number of state court actions pending in New Jersey. New Jersey is also the place where Johnson & Johnson headquarter located, so relevant evidence and witnesses likely are based in the District of New Jersey. Just after the order announced 11 pending cases and 43 more potential actions from around the country reassigned to U.S. District Judge Freda Wolfson of the District of New Jersey. Any future ovarian cancer claims filed in federal courts against Johnson & Johnson are likely to be transferred to New Jersey.

Recently a multi-plaintiff lawsuit has been filed in California state court alleging that the manufacturers were aware of almost 40 years of independent scientific studies which linked the use of their products to higher risk of ovarian cancer when the talc was applied in the genital area but the manufacturers decided to withheld the information as per them the risk was not significant enough to require a product warning. In this multi- plaintiff lawsuit women from all over the nation made similar claims and accuses the manufacturer of recklessly selling it products to market without warning, Due to the negligence and not adequately warning the potential ovarian cancer risks by the manufacturers thousands of women throughout the United States may have developed ovarian cancer and fighting with their lives.

Johnson & Johnson is preparing to fight another legal battle as the number of lawsuits is increasing day by day. Thousands of women have filed lawsuits across the country against Johnson & Johnson alleging that the use of talcum powder leads to ovarian cancer.  Several investigations on talc increase the medical evidence which suggest Women should not use talcum powder as an intimate hygiene powder because of its link to ovarian cancer. The more often a woman uses it on her genital area, the more likely she will experience ovarian cancer. If you’ve developed ovarian cancer and used talcum-based Johnson & Johnson powder product, such as Shower to Shower or Johnson’s Baby Powder please contact Drugsclaim.com for a free talcum powder lawsuit case review. Our accomplished lawyers are dedicated to protecting consumers through class action and individual litigation, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.

About the author

admin

Leave a Comment